Estudos-chave que Influenciam as Minhas Práticas Após a Conferência EACS 2021

October 27-30, 2021; London, United Kingdom
Leitura dos resumos dos membros do corpo docente especialistas dos principais estudos da conferência EACS 2021, incluindo resultados de estudos sobre BIC/FTC/TAF num modelo de teste e tratamento; islatravir e doravirina em pacientes sem tratamento prévio; DTG/3TC em pacientes com uma mutação M184V; CAB + RPV de longa duração por categoria de IMC, satisfação do paciente e resultados após a descontinuação; lenacapavir em pacientes com bastante experiência de tratamento; e eficácia da vacina COVID-19 e o impacto da pandemia na supressão virológica em pessoas com VIH (PWH).
Tristan J. Barber, MA, MD, FRCP
Chloe Orkin Photo
Chloe Orkin, MBChB, FRCP, MD
Jürgen K. Rockstroh, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 698 KB
Released: December 14, 2021

Acknowledgements

Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Gilead Sciences, Inc.
Merck Sharp & Dohme Corp.
ViiV Healthcare

Related Content

Dr Sylvia Ojoo discusses data on cryptococcal meningitis in people with HIV from the fall 2022 HIV conferences, from Clinical Care Options (CCO)

person default Sylvia Ojoo, CCST (UK), MRCP (UK), DTM&H (UK), DFFP (UK), MBChB Released: December 6, 2022

Dr Monica Gandhi discusses key advances in HIV treatment over the past year, from Clinical Care Options (CCO)

Monica Gandhi, MD, MPH Released: December 2, 2022

A patient advocate discusses the importance of community-led HIV treatment and prevention, from Clinical Care Options (CCO)

person default Rena Janamnuaysook, MBA Released: December 2, 2022

Clinical Care Options (CCO) expert analysis of new data from IDWeek and HIV Glasgow 2022, provided by expert HIV faculty

Joseph J. Eron, Jr., MD Karine Lacombe, MD, PhD Released: November 30, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings